Please click here for full article
FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle Mon, 29 Nov 2004 The Food and Drug Administration is the epicenter of a collision between medical officers in the drug safety office and senior officials in managerial positions whose focus is on facilitating new drug approvals. Officials at the…
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
A stunning admission of failure by major drug manufacturers who market drugs for the treatment of Alzheimer’s. "We really believe drugs are failing because we honestly don’t understand the disease."
"For patients, navigating the debate can be difficult because doctors, patient advocacy groups and manufacturers often endorse positions that are in their economic self-interest." The New York Times
An urgent call for a debate about the ethics of data secrecy. Absent the humanitarian raison d’etre for enrolling in a clinical trial, no human being should be put at any–even minimal risk–without adequate compensation as a laborer and the protection of Workmen’s Compensation insurance.
Millions of people around the world participate in research trials each year, whether for personal, financial or humanitarian reasons. They submit their DNA, organs, body chemistry or personal history to studies that aim to better society. A substantive investigative news report by San Diego’s independent investigative news source, Inewsource.org by…
